SUMMERCROFT SURGERY — All Prescriptions & Medications — Page 9
Practice Code: G84006 | ORPINGTON, BR6 7AR
Showing results 401-450 of 567
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder micronutrient supplement (0913291) | 26 | 12.6K | £1.6K | +227.0% ▲ |
| Ciprofloxain/dexameth | 26 | 150 | £175 | -15.3% ▼ |
| 26 | 26 | £61 | -19.8% ▼ | |
| 26 | 2,192 | £847 | +34.5% ▲ | |
| Terbinafine hydrochloride | 25 | 1,302 | £453 | -59.6% ▼ |
| Sodium feredetate | 25 | 14.5K | £412 | -12.7% ▼ |
| Leflunomide | 25 | 960 | £60 | -33.9% ▼ |
| 25 | 249 | £249 | -19.7% ▼ | |
| 25 | 840 | £5.9K | +97.2% ▲ | |
| Nizatidine | 24 | 2,200 | £1.7K | -30.2% ▼ |
| Valsartan | 24 | 2,156 | £504 | -59.3% ▼ |
| Repaglinide | 24 | 2,412 | £165 | -0.7% vs avg |
| Water for injection | 24 | 760 | £258 | -29.1% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 24 | 533.5K | £13.7K | +125.5% ▲ |
| Ivermectin | 24 | 1,080 | £627 | +12.9% ▲ |
| 24 | 300 | £36 | -36.2% ▼ | |
| 24 | 3,090 | £5.1K | +30.4% ▲ | |
| Naratriptan hydrochloride | 23 | 216 | £42 | -12.0% ▼ |
| Oxcarbazepine | 23 | 2,720 | £537 | -17.8% ▼ |
| Trihexyphenidyl hydrochloride | 23 | 2,912 | £227 | -18.9% ▼ |
| Betamethasone sodium phosphate | 23 | 1,415 | £189 | +87.1% ▲ |
| Tube feed 0.75 kcal/ml with fibre (0914021) | 23 | 139.5K | £2.8K | +131.5% ▲ |
| Metronidazole | 23 | 930 | £345 | -38.8% ▼ |
| Midazolam hydrochloride | 23 | 250 | £139 | -43.8% ▼ |
| Bempedoic acid/Ezetimibe | 22 | 1,232 | £2.3K | -64.0% ▼ |
| Semaglutide | 22 | 882 | £3.2K | -90.9% ▼ |
| Vitamin B compound | 22 | 2,548 | £73 | -84.2% ▼ |
| 22 | 1,282 | £714 | -40.7% ▼ | |
| 22 | 95 | £550 | +72.9% ▲ | |
| 22 | 1,150 | £55 | -59.5% ▼ | |
| 22 | 62 | £910 | +59.3% ▲ | |
| 22 | 1,350 | £1.2K | -45.8% ▼ | |
| Glycopyrronium bromide | 21 | 8,670 | £5.8K | +2.3% ▲ |
| Zonisamide | 21 | 2,380 | £1.1K | -51.9% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 21 | 812 | £47 | -47.7% ▼ |
| Insulin degludec | 21 | 110 | £1.0K | -80.9% ▼ |
| Azelaic acid | 21 | 630 | £138 | -12.2% ▼ |
| 21 | 270 | £163 | +14.6% ▲ | |
| 21 | 3,550 | £3.1K | +150.6% ▲ | |
| 21 | 560 | £2.6K | -53.6% ▼ | |
| Labetalol hydrochloride | 20 | 1,736 | £135 | -11.9% ▼ |
| Colesevelam hydrochloride | 20 | 4,320 | £1.7K | -47.3% ▼ |
| Procyclidine hydrochloride | 20 | 2,212 | £84 | -85.9% ▼ |
| Etonogestrel | 20 | 20 | £1.7K | -30.8% ▼ |
| Calcium acetate | 20 | 2,708 | £242 | +8.1% ▲ |
| Pyridostigmine bromide | 20 | 3,950 | £504 | +16.8% ▲ |
| Brimonidine tartrate | 20 | 145 | £69 | -49.9% ▼ |
| Azelastine hydrochloride | 20 | 462 | £210 | +78.4% ▲ |
| 20 | 79 | £152 | -50.9% ▼ | |
| 20 | 142 | £253 | +21.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.